Skip to main content
AAN.com
Brief Communications
December 12, 2005

Comparison of family histories in FTLD subtypes and related tauopathies

December 13, 2005 issue
65 (11) 1817-1819

Abstract

Pedigrees from 269 patients with frontotemporal lobar degeneration (FTLD), including frontotemporal dementia (FTD), FTD with ALS (FTD/ALS), progressive nonfluent aphasia, semantic dementia (SD), corticobasal degeneration, and progressive supranuclear palsy were analyzed to determine the degree of heritability of these disorders. FTD/ALS was the most and SD the least heritable subtype. FTLD syndromes appear to have different etiologies and recurrence risks.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
Rosso SM, van Swieten JC. New developments in frontotemporal dementia and parkinsonism linked to chromosome 17. Curr Opin Neurol 2002;15:423–428.
2.
Binetti G, Nicosia F, Benussi L, et al. Prevalence of TAU mutations in an Italian clinical series of familial frontotemporal patients. Neurosci Lett 2003;338:85–87.
3.
Bird T, Knopman D, VanSwieten JB, et al. Epidemiology and genetics of frontotemporal dementia/Pick’s disease. Ann Neurol 2003;54(suppl 5):S29–S31.
4.
Wilhelmsen KC, Forman MS, Rosen HJ, et al. 17q-linked frontotemporal dementia-amyotrophic lateral sclerosis without tau mutations with tau and alpha-synuclein inclusions. Arch Neurol 2004;61:398–406.
5.
Neary D, Snowden JS, Mann DM. The clinical pathological correlates of lobar atrophy. Dementia 1993;4:154–159.
6.
Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial “Clinical Limits of Amyotrophic Lateral Sclerosis” workshop contributors. J Neurol Sci 1994;124(suppl):96–107.
7.
Litvan I, Hauw JJ, Bartko JJ, et al. Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 1996;55:97–105.
8.
Blacker D, Albert MS, Bassett SS, et al. Reliability and validity of NINCDS-ADRDA criteria for Alzheimer’s disease. The National Institute of Mental Health Genetics Initiative. Arch Neurol 1994;51:1198–1204.
9.
Mehta CR, Patel NR. A network algorithm for performing Fisher’s exact test in r × c contingency tables. J Am Stat Assoc 1983;78:427–434.
10.
Rosen HJ, Hartikainen KM, Jagust W, et al. Utility of clinical criteria in differentiating frontotemporal lobar degeneration (FTLD) from AD. Neurology 2002;58:1608–1715.

Information & Authors

Information

Published In

Neurology®
Volume 65Number 11December 13, 2005
Pages: 1817-1819
PubMed: 16344531

Publication History

Published online: December 12, 2005
Published in print: December 13, 2005

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

J. S. Goldman, MS, MPhil, CGC
From the Memory and Aging Center (J.S. Goldman, Drs. Johnson, Boxer, and Miller), University of California, San Francisco; Center for Neurodegenerative Disease Research (J.M. Farmer, B.M. Wood, Dr. Lee), University of Pennsylvania, Philadelphia; Departments of Genetics and Neurology (Dr. Wilhelmsen), University of North Carolina, Chapel Hill; ALS Center (Dr. Lomen-Hoerth), University of California, San Francisco; Department of Neurology (Dr. Grossman), Hospital of the University of Pennsylvania, Philadelphia; Department of Epidemiology and Biostatistics (Dr. Neuhaus), University of California, San Francisco.
J. M. Farmer, MS, CGC
From the Memory and Aging Center (J.S. Goldman, Drs. Johnson, Boxer, and Miller), University of California, San Francisco; Center for Neurodegenerative Disease Research (J.M. Farmer, B.M. Wood, Dr. Lee), University of Pennsylvania, Philadelphia; Departments of Genetics and Neurology (Dr. Wilhelmsen), University of North Carolina, Chapel Hill; ALS Center (Dr. Lomen-Hoerth), University of California, San Francisco; Department of Neurology (Dr. Grossman), Hospital of the University of Pennsylvania, Philadelphia; Department of Epidemiology and Biostatistics (Dr. Neuhaus), University of California, San Francisco.
E. M. Wood, MS
From the Memory and Aging Center (J.S. Goldman, Drs. Johnson, Boxer, and Miller), University of California, San Francisco; Center for Neurodegenerative Disease Research (J.M. Farmer, B.M. Wood, Dr. Lee), University of Pennsylvania, Philadelphia; Departments of Genetics and Neurology (Dr. Wilhelmsen), University of North Carolina, Chapel Hill; ALS Center (Dr. Lomen-Hoerth), University of California, San Francisco; Department of Neurology (Dr. Grossman), Hospital of the University of Pennsylvania, Philadelphia; Department of Epidemiology and Biostatistics (Dr. Neuhaus), University of California, San Francisco.
J. K. Johnson, PhD
From the Memory and Aging Center (J.S. Goldman, Drs. Johnson, Boxer, and Miller), University of California, San Francisco; Center for Neurodegenerative Disease Research (J.M. Farmer, B.M. Wood, Dr. Lee), University of Pennsylvania, Philadelphia; Departments of Genetics and Neurology (Dr. Wilhelmsen), University of North Carolina, Chapel Hill; ALS Center (Dr. Lomen-Hoerth), University of California, San Francisco; Department of Neurology (Dr. Grossman), Hospital of the University of Pennsylvania, Philadelphia; Department of Epidemiology and Biostatistics (Dr. Neuhaus), University of California, San Francisco.
A. Boxer, MD, PhD
From the Memory and Aging Center (J.S. Goldman, Drs. Johnson, Boxer, and Miller), University of California, San Francisco; Center for Neurodegenerative Disease Research (J.M. Farmer, B.M. Wood, Dr. Lee), University of Pennsylvania, Philadelphia; Departments of Genetics and Neurology (Dr. Wilhelmsen), University of North Carolina, Chapel Hill; ALS Center (Dr. Lomen-Hoerth), University of California, San Francisco; Department of Neurology (Dr. Grossman), Hospital of the University of Pennsylvania, Philadelphia; Department of Epidemiology and Biostatistics (Dr. Neuhaus), University of California, San Francisco.
J. Neuhaus, PhD
From the Memory and Aging Center (J.S. Goldman, Drs. Johnson, Boxer, and Miller), University of California, San Francisco; Center for Neurodegenerative Disease Research (J.M. Farmer, B.M. Wood, Dr. Lee), University of Pennsylvania, Philadelphia; Departments of Genetics and Neurology (Dr. Wilhelmsen), University of North Carolina, Chapel Hill; ALS Center (Dr. Lomen-Hoerth), University of California, San Francisco; Department of Neurology (Dr. Grossman), Hospital of the University of Pennsylvania, Philadelphia; Department of Epidemiology and Biostatistics (Dr. Neuhaus), University of California, San Francisco.
C. Lomen-Hoerth, MD, PhD
From the Memory and Aging Center (J.S. Goldman, Drs. Johnson, Boxer, and Miller), University of California, San Francisco; Center for Neurodegenerative Disease Research (J.M. Farmer, B.M. Wood, Dr. Lee), University of Pennsylvania, Philadelphia; Departments of Genetics and Neurology (Dr. Wilhelmsen), University of North Carolina, Chapel Hill; ALS Center (Dr. Lomen-Hoerth), University of California, San Francisco; Department of Neurology (Dr. Grossman), Hospital of the University of Pennsylvania, Philadelphia; Department of Epidemiology and Biostatistics (Dr. Neuhaus), University of California, San Francisco.
K. C. Wilhelmsen, MD, PhD
From the Memory and Aging Center (J.S. Goldman, Drs. Johnson, Boxer, and Miller), University of California, San Francisco; Center for Neurodegenerative Disease Research (J.M. Farmer, B.M. Wood, Dr. Lee), University of Pennsylvania, Philadelphia; Departments of Genetics and Neurology (Dr. Wilhelmsen), University of North Carolina, Chapel Hill; ALS Center (Dr. Lomen-Hoerth), University of California, San Francisco; Department of Neurology (Dr. Grossman), Hospital of the University of Pennsylvania, Philadelphia; Department of Epidemiology and Biostatistics (Dr. Neuhaus), University of California, San Francisco.
V. M.-Y. Lee, PhD
From the Memory and Aging Center (J.S. Goldman, Drs. Johnson, Boxer, and Miller), University of California, San Francisco; Center for Neurodegenerative Disease Research (J.M. Farmer, B.M. Wood, Dr. Lee), University of Pennsylvania, Philadelphia; Departments of Genetics and Neurology (Dr. Wilhelmsen), University of North Carolina, Chapel Hill; ALS Center (Dr. Lomen-Hoerth), University of California, San Francisco; Department of Neurology (Dr. Grossman), Hospital of the University of Pennsylvania, Philadelphia; Department of Epidemiology and Biostatistics (Dr. Neuhaus), University of California, San Francisco.
M. Grossman, MD
From the Memory and Aging Center (J.S. Goldman, Drs. Johnson, Boxer, and Miller), University of California, San Francisco; Center for Neurodegenerative Disease Research (J.M. Farmer, B.M. Wood, Dr. Lee), University of Pennsylvania, Philadelphia; Departments of Genetics and Neurology (Dr. Wilhelmsen), University of North Carolina, Chapel Hill; ALS Center (Dr. Lomen-Hoerth), University of California, San Francisco; Department of Neurology (Dr. Grossman), Hospital of the University of Pennsylvania, Philadelphia; Department of Epidemiology and Biostatistics (Dr. Neuhaus), University of California, San Francisco.
B. L. Miller, MD
From the Memory and Aging Center (J.S. Goldman, Drs. Johnson, Boxer, and Miller), University of California, San Francisco; Center for Neurodegenerative Disease Research (J.M. Farmer, B.M. Wood, Dr. Lee), University of Pennsylvania, Philadelphia; Departments of Genetics and Neurology (Dr. Wilhelmsen), University of North Carolina, Chapel Hill; ALS Center (Dr. Lomen-Hoerth), University of California, San Francisco; Department of Neurology (Dr. Grossman), Hospital of the University of Pennsylvania, Philadelphia; Department of Epidemiology and Biostatistics (Dr. Neuhaus), University of California, San Francisco.

Notes

Address correspondence and reprint requests to J.S. Goldman, UCSF Memory and Aging Center, 350 Parnassus Avenue, Suite 706, San Francisco, CA 94117; e-mail: [email protected]

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Primary Progressive Aphasia: Variants and Main Language Domains, Annals of Clinical and Experimental Neurology, 18, 4, (68-75), (2025).https://doi.org/10.17816/ACEN.1067
    Crossref
  2. Frontotemporal dementia, Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease, (35-57), (2025).https://doi.org/10.1016/B978-0-443-19176-3.00032-7
    Crossref
  3. Parkinson's disease and related disorders, Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease, (19-33), (2025).https://doi.org/10.1016/B978-0-443-19176-3.00023-6
    Crossref
  4. Primary progressive aphasia, Encyclopedia of the Human Brain, (486-500), (2025).https://doi.org/10.1016/B978-0-12-820480-1.00125-X
    Crossref
  5. Genetic Screening of Patients with Sporadic Alzheimer’s Disease and Frontotemporal Lobar Degeneration in the Chinese Population, Journal of Alzheimer's Disease, 99, 2, (577-593), (2024).https://doi.org/10.3233/JAD-231361
    Crossref
  6. Neuropsychiatric Symptoms in Frontotemporal Dementia: More Than Just Noise?, Journal of Alzheimer's Disease, 98, 1, (133-144), (2024).https://doi.org/10.3233/JAD-231256
    Crossref
  7. Predictors of Care Home Admission and Survival Rate in Patients With Syndromes Associated With Frontotemporal Lobar Degeneration in Europe, Neurology, 103, 7, (2024)./doi/10.1212/WNL.0000000000209793
    Abstract
  8. Genetic testing in dementia, Practical Neurology, (pn-2024-004241), (2024).https://doi.org/10.1136/pn-2024-004241
    Crossref
  9. Huntington’s disease phenocopy syndromes revisited: a clinical comparison and next-generation sequencing exploration, Journal of Neurology, Neurosurgery & Psychiatry, (jnnp-2024-333602), (2024).https://doi.org/10.1136/jnnp-2024-333602
    Crossref
  10. Clinical and imaging correlates of hyperorality in syndromes associated with frontotemporal lobar degeneration, Psychiatry and Clinical Neurosciences, 78, 12, (818-825), (2024).https://doi.org/10.1111/pcn.13751
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Figures

Tables

Media

Share

Share

Share article link

Share